Related Experiment Video
Updated: Feb 8, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
[Prevention of recurrent hepatocellular carcinoma with retinoid]
1Department of Internal Medicine I, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu 500-8705, Japan.
Abstract:
The annual rate of recurrent hepatocellular carcinoma (HCC) after curative treatment of the initial tumor is reportedly as high as 20-25%. Such a high recurrence rate is responsible for the poor prognosis of patients with HCC. One third of the recurrent HCC arises from intrahepatic metastasis of the initial tumor, one third from multicentric carcinogenesis, and one third from unknown origin. In any type of recurrence, elimination of the transformed cell clone from the remnant liver is essential to prevent the recurrence of HCC. A retinoid analog, acyclic retinoid, induces differentiation and apoptosis of HCC cell lines in vitro. An early clinical trial showed a preventive effect of the compound on recurrent HCC. A further trial of acyclic retinoid is now under way.
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...

